Unigrilin 75 (Eptifibatide Vials) 75mg/100ml

Unigrilin 75 is an injectable eptifibatide formulation in 75mg/100ml vials, used for blood clot prevention in cardiac care. This antiplatelet agent supports procedures like angioplasty by reducing platelet aggregation. Store between 2-8°C to maintain potency. Ideal for hospital and clinical settings.

Strength

75mg/100ml

Pack Size

1's

Storage

2-8°

Manufacturer / TM Owner

United Biotech (P) Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eptifibatide, the active ingredient in Unigrilin 75, is used to prevent blood clots during certain heart-related procedures such as angioplasty or stent placement. It belongs to a class of medications called antiplatelet drugs, which work by preventing platelets in the blood from sticking together. This helps reduce the risk of clot formation that could block arteries. It is typically administered in a clinical setting under medical supervision.

Side Effects

Unigrilin 75 works by temporarily inhibiting platelet aggregation, which can help maintain blood flow in coronary arteries during high-risk cardiac procedures. Patients may experience improved procedural outcomes due to reduced clot risk. Common effects include changes in bleeding patterns, as the medication affects how blood clots form. These effects are closely monitored by healthcare providers.

Precautions & Warnings

Unigrilin 75 should only be handled and administered by trained healthcare professionals in a controlled environment. It requires careful storage at 2-8°C to preserve its stability. Patients with a history of bleeding disorders or recent surgeries should be closely evaluated before use. Always inform your healthcare provider about current medications and medical conditions.

Avoid Interactions

Unigrilin 75 may interact with other medications that affect blood clotting, such as anticoagulants or nonsteroidal anti-inflammatory drugs (NSAIDs). Combining it with certain drugs could increase the risk of bleeding. It is important to disclose all medications, including over-the-counter products, to your healthcare provider. Alcohol and herbal supplements may also influence its effects.

References

Frequently Asked Questions

Eptifibatide is used to prevent blood clots during heart procedures like angioplasty.

It is given as an intravenous injection in a clinical setting by healthcare professionals.

Online purchase of prescription medications like Unigrilin 75 is subject to local regulations and requires a valid prescription.

Common effects may include changes in bleeding patterns, which are monitored during treatment.

Safety during pregnancy should be discussed with a healthcare provider, as effects may vary.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.